Source: Eur Respir J, 52 (5) 1801386; 10.1183/13993003.01386-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sanne M.H. Zweijpfenning, Hester van Groningen, Jakko van Ingen, Cecile Magis-Escurra, Martin J. Boeree, Dirk Wagner, Hannelore Bax, Claire Andrejak, Reinier Wener, Ananna Rahman, Heinke Kunst, Natalie Lorent, Marc A. Brouwer, Wouter Hoefsloot. Clofazimine does not lead to significant QT interval prolongation: a multicentre study. Eur Respir J, 52 (5) 1801386; 10.1183/13993003.01386-2018

Member's Comments

No comment yet.

Related content which might interest you: The antitussive pentoxyverine (POV) does not affect the electrocardiogram (ECG), and in particular not the corrected QT (QTc) interval: Results from a phase I clinical trial Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy Source: Eur Respir J, 51 (2) 1702368; 10.1183/13993003.02368-2017 Year: 2018 Exercise-induced changes in QT interval are smaller in COPD patients and have no impact on mortality Source: Eur Respir J , 49 (3) 1602394; DOI: 10.1183/13993003.02394-2016 Year: 2017 Glycopyrronium does not affect QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 The effects of bedaquiline and fluoroquinolone-based treatment regimens in patients with MDR/XDR-TB on QT prolongation Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 QT dispersion in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003 Improvement of the clinical response to infiximab in refractory sarcoidosis by reducing the dose interval Source: Eur Respir J 2007; 30: Suppl. 51, 245s Year: 2007 Incidence and predictors of QT interval prolongation in the intensive care units of a tertiary pulmonary center Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Assessment of atrial overdrive pacing as a treatment for OSAHS. (A prospective, randomized crossover study) Source: Eur Respir J 2005; 26: Suppl. 49, 564s Year: 2005 Indacaterol, a novel β2-agonist, demonstrates 24-hour efficacy and is well tolerated in patients with asthma: a multiple-dose, dose-ranging study Source: Eur Respir J 2005; 26: Suppl. 49, 253s Year: 2005 Short-term linear and nonlinear ("chaotic") characteristics of R-R interval dynamics in patients with sarcoidosis Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Aclidinium bromide, a novel long-acting anticholinergic, does not affect QT interval in healthy subjects Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 RCT Abstract - Ad26.COV2.S immunogenicity in a Phase 2 trial at different booster dose levels and schedule intervals in adults Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021 Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016 Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial Source: Eur Respir J, 56 (6) 2002808; 10.1183/13993003.02808-2020 Year: 2020 Bilevel ST therapy versus servoventilation for complex sleep apnea – A randomized trial Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010 Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018 Year: 2018 COPD maintenance therapy is related to left heart size: Results from the multicenter long-term observation COSYCONET Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study Source: Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018 Year: 2018